Спайдер незначительно повышается перед открытием торгов на NYSE.
Европейские индексы на отрицательной территории.
SPY (внутридневной график) рост на премаркете. Сопротивление: 170.00 Поддержка: 169.20
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: ASNA +13.3%.
M&A news: MAKO +82.4% (acquired by Stryker (SYK) for $30/share in cash).
Select EU Telecomrelated names showing strength: ORAN +3.2%, VOD +1.3%, ALU +0.9%.
Select metals/mining stocks trading higher: RIO +2.3%, AU +2.2%, IAG +1.6%, BHP +1.2%.
Other news: ONTY +21.7% ( announces Merck Serono, unit of Merck KGaA (MKGAY.PK), decision to continue the development of tecemotide in stage III non-small cell lung cancer), CTIC +11.3% (cont strength; potentially related to MYGN news - see below), PRTS +6.2% (Maguire Asset Management seeks to purchase Oak Investment Partners' approximate 28% ownership in U.S. Auto Parts), DVAX +5.9% (announced that positive Phase 3 data on HEPLISAV in adults aged 40-70 and patients with chronic kKidney disease was published in the journal VACCINE), SZYM +5.9% (and Unilever (UL) sign commercial supply agreement for Tailored Algal Oil), NTLS +3.8% (settled open dispute with Sprint related to their Strategic Network Alliance; raised FY13 EBITDA guidance), MYGN +3.7% (myPlan Lung Cancer test meets primary clinical endpoint), NE +2.8% (announced plan to create independent standard specific drilling company), BRCD +2.8% ( increases the authorization to repurchase its common stock from $308 mln to $1 bln), OPXA +2.1% (announces the conversion of the co's outstanding 12% convertible secured promissory notes into shares of common stock), SUNE +2% (S.A.C. Capital Advisors disclosed 5.1% passive stake) ANW +1.4% (signed $1 bln secured borrowing base multicurrency revolving credit facility), WR +1% (prices 8 mln shares of common stock at $31.15 per share), BERY +1% (appeared on Mad Money yesterday), .
Analyst comments: SSNI +6.2% (upgraded to Buy from Neutral at Goldman), CTRP +5.1% (upgraded to Buy from Hold at Deutsche Bank), BOBE +4.2% (target raised to $67 at Oppenheimer), MW +2% (initiated with a Buy at Goldman), FB +1.5% (initiated with a Buy at Canaccord Genuity, also target raised to $54 at Oppenheimer), ROST +1.5% (added to Conviction Buy List at Goldman),
Gapping down:
In reaction to disappointing earnings/guidance: LNDC -12.7%, CPRT -9.9%, ATE -6.2%, AIR -6.1%, CCK -4.5%.
M&A news: CLVS -13.6% (Bloomberg reporting that co received no interest from potential buyers), TI -2.1% (Telefonica (TEF) will slowly take control of TI, but will avoid full takeover, according to reports).
Other news: IDRA -4.3% (announced public offering of common stock and pre-funded warrants; size not disclosed), INFI -3.3% (Reports Topline Data from Phase 2 Study of Retaspimycin Hydrochloride), QIWI -1.3% (commences public offering of 8,197,866 of its Classs B ADSs by selling shareholders), INTL -0.8% (announced new three year credit facility).
Analyst comments:CCL -4.1% (downgraded to Underweight from Equal-Weight at Morgan Stanley, downgraded to Reduce from Neutral at Natixis), SWKS -1.2% (downgraded to Neutral from Buy at B. Riley & Co), BBRG -0.9% (downgraded to Neutral from Overweight at Piper Jaffray).
Спайдер незначительно понижается перед открытием торгов на NYSE.
Европейские индексы на положительной территории.
SPY (внутридневной график) боковое движение на премаркете. Сопротивление: 170.00 Поддержка: 169.40
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: KMX +5.5%, LEN +1.3%.
M&A news: JNY +7.8% (reports suggesting co may be acquired for $17-18 per share), AMAT +6.4% (co and Tokyo Electron (TOELY) to merge; creating a new company as a merger of equals with combined market capitalization of ~$29 bln).
Other news: GWAY +18.3% (co and Vitera Healthcare Solutions to combine), INO +7.9% (announces publication of a peer-reviewed paper demonstrating the success of its new DNA plasmid technology), OCN +4.4% (announces credit facility amendment and repurchase from WL Ross & Co), BNNY +3.1% (to replace CBST in the S&P SmallCap 600), NOV +2.5% (announces plan to pursue spin-off of distribution business into separate publicly traded company), MCP +2.1% (China will most likely increase its purchase of rare earth reserves next month, according to reports), SQNM +1.8% (announced review of strategic alternatives for its Genetic Analysis business segment), TI +1.7% (Telefonica (TEF) paid out a capital increase in Telco), ELX +1.4% (Elliot disclosed 6.4% activist stake in amended 13D filing), IGT +0.9% (and Caesars Entertainment ink video poker deal to supply 7,000 AVP video poker terminals).
Analyst comments: TOT +2.2% (upgraded to Equal Weight from Underweight at Barclays), CBEY +2.2% (upgraded to Outperform from Mkt Perform at Raymond James), FB +2.1% upgraded to Buy from Neutral at Citigroup), SD +2.1% (assumed with a Neutral at Goldman), MCHP +1.2% (upgraded to Buy from Neutral at Goldman), AAPL +0.6% (upgraded to Positive from Neutral at Susquehanna)
Gapping down:
In reaction to disappointing earnings/guidance: RHT -10.6%.
Other news: ETRM -8.3% (on track for approval decision in 1H14 following formal response to premarket approval application from FDA), ABR -5.2% (announced it has commenced a public offering of 6 mln shares of common stock), EOX -2.8% (receivedcommitment from White Deer to acquire common stock; announced public offering of 15 mln shares of common stock) NVAX -1.6% (prices Public Offering of Common Stock at $3.14/share), POT -1.6% (potentially related to CIC Chinese fund takes 12% stake in Uralkali), HTZ -1.4% HTZ -1.4% (CFO Elyse Douglas has stepped down), P -1.2% (cont downward momentum), MOS -1.2% (potentially related to news similar to POT)
Analyst comments: FFIV -2.2% (downgraded to Neutral from Buy at Goldman), WPX -1.6% (initiated with a Sell at Goldman).
Интересные новостные акции NYSEи NASDAQ:
LEN – лонг выше максимумов премаркета
FB – шорт ниже 48.00, лонг выше максимума премаркета
Спайдер понижается перед открытием торгов на NYSE.
Европейские индексы на отрицательной территории.
SPY (внутридневной график) снижение на премаркете. Сопротивление: 170.60 Поддержка: 170.00
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: AAPL +3.3% (announces it has sold 9 mln new iPhone 5s and iPhone 5c models), .
M&A news: YONG +4% (enters into definitive merger agreement, shares will be converted into the right to receive $6.69 in cash without interest), .
Other news: VGZ +10.4% (provides strategic update), MXC +5.4% (announces additional development of properties), GIVN +5% (receives clearance for the third generation PillCam SB System in Japan), SKH +3.2% (announces initial HUD loan funding), DRYS +2.6% (cont volatility), TTWO +2.3% (reports of strong GTA 5 sales over weekend), TSEM +1.8% (co and DMB Technology announced volume production and shipping results), SWIR +1.8% (still checking), CWH +1.5% (announces restructuring of management agreement with RMR and significant governance enhancements), OMC +1.2% (still checking), GE +0.9% (co and Sonelgaz affiliate, SPE, sign contracts valued at $2.7 bln to help power Algeria), LNG +0.8% (announces filing of Registration Statement for Cheniere Energy Partners LP IPO).
Analyst comments: MXIM +2.1% (upgraded to Buy from Neutral at Goldman; added to Conviction Buy List), DDD +1.4% (initiated with a Buy at BofA/Merrill), SPLK +1.3% (initiated with a Neutral at Goldman- light vol), WAG +1.3% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
Gapping down:
In reaction to disappointing earnings/guidance: ACTS -4.6%.
M&A news: OPAY -1.5% ( to be acquired by ACI Worldwide (ACIW) for $8.35 per share in cash).
Select financial related names showing weakness: BCS -1.9%, GS -1%, LYG -0.8%, JPM -0.8%, MS -0.7%.
Other news: FSM -6.7% (completes 1,800 tpd mill expansion on-time and on-budget at the San Jose Mine, Mexico), C -2.4% (may have large drop in trading revenue in Q3, according to reports), P -1.8% (reports Apple is paying $0.01 more per song in royalties to record cos vs Pandora, cautious blog article making rounds), JCP -1.7% (in talks to raise more capital, according to reports), KNDI -1.5% (files for 1,255,462 share offering of common stock issuable upon exercise of warrants by selling shareholders), NSC -0.7% (announces retirement of CFO John Rathbone, names Marta Stewart CFO).
Analyst comments: BBRY -6.4% (downgraded to Hold from Buy at Jefferies, also downgraded to Underperform from Sector Perform at RBC Capital Mkts), RNA -5.5% (downgraded to Neutral from Buy at Citigroup - timing unclear), CTRX -2.7% (downgraded to Equal-Weight from Overweight at Morgan Stanley), KORS -1.3% (downgraded to Hold from Buy at Jefferies), NGG -1% (downgraded to Neutral from Buy at UBS), SEE -0.7% (downgraded to Equal Weight from Overweight at Barclays).
Интересные новостные акции NYSEи NASDAQ:
SCTY – лонг выше 38.00
C – шорт ниже минимума премаркета, при закреплении выше 50.00 – лонг.
SPY (внутридневной график) снижение движение на премаркете. Сопротивление: 172.20 Поддержка: 171.50
ПремаркетNYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: TIBX +7.8%, NQ +4.3%, CTAS +3%.
M&A news: VRNM +58.6% (enters agreement to be acquired by BASF (BASFY) for $4.00 per share in cash).
Other news: CYCC +35.3% (sapacitabine reported to have anti-tumor activity against ovarian cancer), JKS +6.3% (prices 3.8 mln ADS follow on offering at $16.25), GT +4.4% (reconfirmed its outlook for 2013 segment operating income; Reinstates cash dividend on common stock, announces share repurchase program), NAVB +4.2% (independent investigators reported Lymphoseek results in JAMA Otolaryngology Head and Neck Surgery), TSPT +2.7% (Roumell Asset Management issued letter to Board: 'Retrophin offer of $4 per share is woefully inadequate'), JCP +2.1% (Vornado (VNO) selling 13.4 mln share stake), KIOR +1.7% (provides operational update on Columbus Facility: as of August 31, 2013), AAPL +1.6% (launches iPhone 5s and 5c today), HIMX +1.6% (still checking), SSTK +1.4% (prices 4.6 mln share follow on offering of common stock at $60.00 per share; shares offered by co and selling shareholders), LGF +1.3% (CFO James Keegan retiring, will be succeeded as CFO by former Viacom CFO James Barge), KNDI +1.2% (cont strength).
Analyst comments: SUNE +2.5% (upgraded to Outperform from Sector Perform at RBC Capital Markets), URBN +2.3% (upgraded to Buy from Hold at Canaccord Genuity), PIR +1.7% (upgraded to Outperform from Neutral at Credit Suisse), NTAP +-1.6% (downgraded to Underperform from Mkt Perform at William Blair), MET +1.2% (added to Conviction Buy List at Goldman), FLML +0.8% (initiated with Mkt Outperform at JMP Securities)
Gapping down:
In reaction to disappointing earnings/guidance: AKS -12.2%, TWI -5.6%, DRI -4.4%, FOXF -3.4%.
Select Indian related names showing weakness after RBI rate hike: TTM -1.9%, IBN -3.4%, HDB -1.9%.
Select metals/mining stocks trading lower: GFI -3.2%, AU -2.6%, GOLD -2.2%, SLV -2.2%, SLW -1.7%, ABX -1.7%, GG -1.7%, X -1.3% (also AKS and MT peer), GLD -1.2%.
Select shipping related names sinking early: BALT -9.8% (announced common stock offering), NMM -5.9% (announced public offering of 5 mln common units), FRO -5.8%.
Other news: RNA -77.6% (co and and GSK announce primary endpoint not met in Phase 3 study of Drisapersen), SRPT -6.5% (related to GSK/RNA news), KAR -2.7% (announced secondary offering of 12 mln shares of common stock by existing stockholder KAR Holdings II, LLC), KAR -2.7% (prices 12 mln share offering (selling stockholder, KAR Holdings II) at $27.35/share), AFH -2.5% (filed for ~1.26 mln share common stock offering by selling shareholders), AEM -1.6% (announced development project update - La India commissioning underway and mining and processing has restarted at Goldex), NEE -1.6% (to sell $500 mln of equity units), NEE -1.6% (agreed to sell $500 mln of equity units to Citigroup (C), Morgan Stanley (MS), and Credit Suisse (CS)), RBS -1.1% (plans to sell Direct Line for GBP 630 mln, according to reports), NLY -0.7% (announced Q3 dividend of $0.35 per share vs $0.40 in prior quarter).
Analyst comments: MT -1.9% (downgraded to Sector Perform from Outperform at RBC Capital Markets), BRKR -1.9% (downgraded to Market Perform from Outperform at Wells Fargo), SWI -1.8% (downgraded to Sell from Neutral at Goldman), NTAP -1.6% (downgraded to Underperform from Mkt Perform at William Blair), CLX -1% (downgraded to Underperform from Neutral at Credit Suisse), SIAL -1% (downgraded to Neutral from Outperform at Robert W. Baird), AIZ -0.9% (downgraded to Neutral from Buy at Goldman), NLSN -0.8% (downgraded to Mkt Perform from Outperform at Bernstein, initiated with a Neutral at Goldman).
Мы решили немного упростить жизнь всем трейдерам. Причем абсолютно безвозмездно. В России это называется халявой.
Мы готовы абсолютно бесплатно написать и протестировать любую вашу стратегию (кроме HFT) на исторических данных. Рынок может быть любой: Forts, NYSE, Forex, CME. Если сможете предоставить котировки биткоинов в текстовом формате — протестируем на них:). От вас потребуется четкое ТЗ. Например, такое: торгую “по Герчику” вход в сделку по тренду (описываете как понимаете тренд) в базе из N свечей, стоп за последнюю 15 минутку, на дневке — аптренд; хочу протестировать на портфеле акций из SP500.
Кому это нужно? Прежде всего вам. Многие пытаются системно торговать руками и корят себя за неследование системе, хотя даже не знают зарабатывает система или нет, есть ли у нее положительное мат. ожидание на длительном промежутке времени. От нас вы получаете код торговой стратегии и результаты бектеста. Желательно, чтобы стратегия была действительно интересной и обоснованной. Например, покупка после 5% падения вниз при закрытии 15 минутки зеленой. Стратегии состоящие только из индикаторов мы, конечно, тоже сможем протестировать...но нам бы не хотелось тратить время на заведомо нерабочие вещи. При большом потоке заявок мы оставляем за собой право выбирать наиболее интересные варианты.
Какая выгода от этого нам? Что скрывать, это желание пиара, конечно. Но мы хотим сделать все максимально полезно для всех. Вы присылаете нам стратегию, мы ее кодим, тестируем. Результаты и код выкладываем в открытый доступ на Смарт-лаб и на наш сайт для обсуждения. Вы делаете вывод для себя, приносите пользу обществу (в виде общедоступного кода).
Тестирование будет проводиться на лицензионном терминале Multicharts.Net, соответственно, готовые коды тоже будут в формате MC.
Прислать ТЗ можно личным сообщением на смарт-лабе или на почту info@shark-traders.com
. При отправке ТЗ вы заведомо соглашаетесь с тем, что стратегия и ее код попадают в открытый доступ, никакая персональная информация опубликована не будет.
Результаты по присланным торговым стратегиям мы начнем публиковать с понедельника на смарт-лабе и на нашем сайте с тегом “shark traders тестирование”.
Спайдер повышается перед открытием торгов на NYSE.
Европейские индексы на положительной территории.
SPY (внутридневной график) рост движение на премаркете. Сопротивление: 174.00 Поддержка: 173.00
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: RAD +13.2%.
M&A news: MCBI +24.4% (co and East West Bancorp (EWBC) enter into definitive agreement for merger), BMRN +8.9% (Bloomberg discusses speculation that Roche (RHHBY) may secure financing for BMRN bid, according to reports).
Other news: ACUR +12.6% (provided update on NEXAFED launch: now being sold in over 2,600 pharmacies nationwide), A +11.3% (to separate into two public companies; spinoff is not anticipated to impact co's guidance for fiscal year 2013), ONVO +10.4% ( diclosed it entered into an agreement with Hoffmann La Roche exploring the use of 3D liver tissue in toxicology), TSPT +10% (Retrophin proposed acquisition of co for $4 per share), KNDI +7.5% (confirms Chinese Government issued 2013-2015 subsidy policy for new energy vehicles), TTWO +4.7% (Grand Theft Auto V sales may have hit ~ $1 bln worldwide during first day of launch, according to reports), ISIS +3.7% (reports follow-up data from iSIS-SMN Rx Phase 1 study in children with spinal muscular atrophy), HIMX +2.8% (cont strength), TTM +2.6% (strong move in the Sensex overnight), IBN +1.9% (stong Sensex mkt overnight), MT +1.8% (ArcelorMittal and Technip (TKPPY) signed contract for the supply of high-performance steel wires), ICUI +1.8% (reports two new clinical studies show ChemoClave System improves safety), AAPL +1.1% (WantChinaTimes discusses declining market share for AAPL in China).
Analyst comments: GTAT +7.3% (upgraded to Buy from Neutral at UBS), GRPN +3.6% ( upgraded to Buy at Stifel), TSLA +2.6% (tgt raised to $200 from $160 at Deutsche Bank), HERO +2.4% (reinstated with a Buy at Deutsche Bank), DEO +2% (upgraded to Outperform from Mkt Perform at Bernstein), DEG +1.7% (upgraded to Buy from Neutral at Nomura), TWX +1.7% (upgraded to Overweight from Equal-Weight at Morgan Stanley), AG +1.6% (upgraded to Strong Buy from Outperform at Raymond James)
Gapping down:
In reaction to disappointing earnings/guidance: PIR -7.8%, SCS -5.4%, APOG -3.4%, MLHR -2%, CLC -1.2%, CAG -1.2%.
Other news: ROYT -7.1% (announces public offering by selling unitholders of 13.5 mln units), ARR -4.3% (lowered Q4 dividend to $0.05 from $0.07 per share in prior quarter), SSNC -3.7% (filed for 7,469,799 share common stock offering by selling shareholders), FSC -3.5% (commenced public offering of 15 mln shares of common stock), SSH -3.1% (announced proposed public offering of common shares; size not disclosed), ATVI -1.4% (announced that a court ruled to halt the closing of a transaction with Vivendi), HTS -1.4% (lowered quarterly dividend 21% to $0.55 per share).
Analyst comments: DIS -1% (downgraded to Equal-Weight from Overweight at Morgan Stanley), CSCO -1% (initiated with an Underperform at Credit Suisse).
Интересные новостные акции NYSEи NASDAQ:
ABX – шорт ниже 20.00
PIR – лонг выше 22.00
CAG – лонг выше 32.00, ниже минимума премаркета смотрим акцию в шорт
ORCL – лонг выше 34.00
A – шорт ниже 52.00, выше 54.00 смотрим акцию в лонг.
Спайдер незначительно повышается перед открытием торгов на NYSE.
Европейские индексы на положительной территории.
SPY (внутридневной график) боковое движение на премаркете. Сопротивление: 171.00 Поддержка: 171.50
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: AFOP +13.4%, ADBE +5.7%, FDX +2.8%, GIS +0.6%.
M&A news: GRPN +0.8% (cquires local experience startup SideTour).
Select EU financial related names showing strength: IRE +1.9%, SAN +1.9%, HBC +1.4%, BCS +1.2%.
Other news: CIS +0% (enters into a merger agreement for a 'going private' transaction;), INVN +4.9% (still checking), DLTR +3.5% (announced $2 bln share repurchase authorization) CPRX +2.4% (still checking), WDAY +1.2% (Salesforce.com (CRM) announced plans to integrate the entire Salesforce and Workday product lines), AAPL +1.1% (releasing iOS 7 today, also Pacific Crest's increases estimates), BMRN +1% (possitive mention on Mad Money), CRZO +1% (possitive mention on Mad Money).
Analyst comments: FI +4.9% (initiated with an Overweight at Barclays, initiated with a Buy at UBS), NOK +3.5% (upgraded to Outperform from Neutral at Credit Suisse), AON +2.2% (initiated with a Buy at Guggenheim), VIPS +1.8% (upgraded to Buy from Hold at Deutsche Bank), ARUN +1.5% (initiated with an Overweight at Piper Jaffray), CL +1.2% (upgraded to Overweight from Equal Weight at Barclays), CTSH +1.1% (upgraded to Overweight from Equal Weight at Barclays).
Gapping down:
In reaction to disappointing earnings/guidance: CBRL -2.8%, AXLL -0.9%.
Other news: CBMX -6.7% (filed for $10 mln offering of Class A Units and Class B Units), FIVE -3.2% (announced secondary offering of 7.1 mln shares by selling shareholders; Executive Chairman to sell 100k shares), FLTX -2.2% (prices follow-on offering of 5,976,443 of its ordinary shares at a price to the public of $46.79/share), QIWI -1.6% (public offering of 8,197,866 ADSs by selling shareholders).
Analyst comments: VPHM -1.9% (downgraded to Neutral from Buy at BofA/Merrill), JOY -1.2% (downgraded to Neutral at Robert W. Baird ), INTU -1% (downgraded to Underweight from Equal-Weight at Morgan Stanley), PG -0.9% (downgraded to Equal Weight from Overweight at Barclays), NRG -0.8% (downgraded to Neutral from Buy at Goldman; removed from Conviction Buy list), CLX -0.7% ( downgraded to Underweight from Equal Weight at Barclays), CAT -0.6% (downgraded to Neutral at Robert W. Baird).
Other news: RPRX +31.1% (reports preliminary findings: Second Pivotal study and 6-month safety study support Androxal approvability), KYTH +30.5% (announced positive ATX-101 top line Phase 3 trial results for the reduction of submental fat), AGEN +23.7% ('positive' follow-on Phase 2 Results for Brain cancer vaccine in newly diagnosed patients;), ARO +12.1% (Hummingbird disclosed a 7.96% active stake in a 13D filing ), DFS +4.9% (reports August card metrics), BCRX +2.8% (awarded contract by the National Institute of Allergy and Infectious Diseases to develop BCX4430 for the treatment of Marburg virus disease), TPLM +2.2% (expands Caliber Infrastructure System), BSX +2.2% (reports favorable six-month results from Lotus Valve System clinical trial), RMTI +1.9% (FDA acceptance of Triferic as proprietary trade name for investigational iron-delivery drug SFP), PERI +1.7% (bounce following yest weakness), TTWO +1.6% (GTA release today), SNY +1.4% (Genzyme receives European Commission approval for multiple sclerosis treatment Lemtrada).
Analyst comments: DAL +2.4% (upgraded to Overweight from Neutral at JP Morgan), LCC +2.4% (upgraded to Overweight from Neutral at JP Morgan), SOHU +2.3% (upgraded to Buy from Neutral at Goldman; added to Conviction Buy list), VOLC +2% (upgraded to Outperform from Mkt Perform at BMO Capital Markets), DDD +1.9% (initiated with an Outperform at Credit Suisse),BRCM +1.4%(upgraded to Positive from Neutral at Susquehanna), APA +1.1% (upgraded to Outperform at Oppenheimer
Gapping down:
In reaction to disappointing earnings/guidance: OUTR -16.3%, CVT -9.4%, OCLR -5.5%, WERN -4.8%, FDS -1%.
Other news: FFHL -9% ( Learns result of auction of controlling interest), JKS -4.9% (announced the offering of 3.5 mln American Depositary Shares), P -3.1% (filed for 14 mln share common stock offering, with 4 mln shares being sold by selling stockholder), LYG -3% (Britan has begun 6% stake sale has has been priced at 75-76 pence per share, according to reports citing sources), MTW -2.9% (announced the termination of its potential joint venture with Shantui Investment co), JRCC -2.8% (adjusts production in Central Appalachia in response to continued weak coal markets), CE -2.3% (increases prices on Acrylic Emulsions in Americas), MOS -2.1% (loweredQ3 price and volume guidance for Potash and Phosphates segments; sees potash volume of 1.45-1.65 mln tonnes, realized price of $330-340 per tonne) PHG -2% (plans $2 bln share buyback and has increased financial targets, according to reports), IPI -1.4% (MOS peer), POT -1.2% (MOS peer), TSLA -1.2% (California New Car Dealers Associatiom investigating TSLA's a lease finance program, according to reports, also GM plans to introduce affordable electric cars, according to reports).
Analyst comments: BGFV -2.9% (downgraded to Neutral from Overweight at Piper Jaffray), CAG -1.6% (downgraded to Neutral from Overweight at JP Morgan), K -1.3% (downgraded to Underweight from Neutral at JP Morgan), FITB -1% (downgraded to Neutral from Buy at Goldman), IACI -0.7% (downgraded to Sector Perform from Outperform at RBC Capital Markets), XONE -0.6% (initiated with a Underperform at Credit Suisse).
Спайдер повышается перед открытием торгов на NYSE.
Европейские индексы на положительной территории.
SPY (внутридневной график) рост на премаркете. Сопротивление: 171.50 Поддержка: 171.00
Премаркет NYSE/NASDAQ:
Gapping up:
M&A news: BZ +26.7% (to be acquired by Packaging Corp. of America (PKG) for $12.55 per share in cash), PKG +10.9% (acquisition is expected to be accretive to earnings immediately), SOHU +7.1% (Sohu.com, Sogou and Tencent (TCEHY) jointly announce strategic cooperation).
Select Potash related names showing strength; move attributed to speculation that Belarus issues will be resolved: CF +2%, POT +1.9%, MOS +1.7%.
Select metals/mining stocks trading higher: CLF +2.9%, MT +2.7%, X +1.7%, BHP +1.7%, RIO +1.5%.
Select solar related names showing strength ahead of this weekend's summit in China: YGE 4%, STP 3.8%, JKS 1.9%, SPWR 1.1%.
3D related names showing early strength; still searching on catalyst - all on light volume: DDD +2.4%, XONE +2.3%, SSYS +1.7%.
Other news: PSTI +8.7% ( FDA lifts clinical hold on co's Phase II intermittent Claudication study), BTH +7% (cont strength following positive blog mention on Friday), LLEN +4.1% (enters new energy business initiative in Beijing), YELP +3.3% (still checking), DAL +2.8% (cont strength from last week), MU +2.5% (sees reduced DRAM supplies, according toreports), P +1.9% (potentially Cumulus Media has agreed to an online radio deal with music service Rdio, according to reports), TSLA +1.3% (still checking, reports of co working on new hybrid battery, increasing range by 40%), GSK +1.3% (FDA grants GSK and Genmab's Arzerra (ofatumumab) Breakthrough Therapy Designation for previously untreated chronic lymphocytic leukemia), BA +1% (nearing S Korea jet deal, according to reports).
Analyst comments: HUN +2.5% (upgraded to Buy from Hold at Jefferies), MOH +2.2% (upgraded to Buy from Hold at Jefferies), WU +2.1% (upgraded to Buy from Neutral at Sterne Agee), AZN +2.1% (upgraded to Buy from Sell at Nordea), BMY +2% (upgraded to Overweight from Neutral at JP Morgan).
Gapping down:
Briefing note: With Stock Index futures ~+1% this morning, only a handful of names are gapping lower. The following represent the most notable early names.
M&A news: QIHU -6.1% (potentially related to news that Sohu, Sogou and Tencent Holdings jointly announced the establishment of a strategic cooperation, it was speculated that QIHU may purchase Sogou).
Select metals/mining stocks trading lower with Gold and Silver ETFs trading lower: SLV -1.8%, AUY -1.6%, AG -1.6%, PAAS -1.3%, SLW -1%, GLD -0.9%, GG -0.9%.
Other news: PERI -5.2% (announces agreement to combine Conduit's Client Connect business with Perion in an all-stock transaction; immediately accretive), KCAP -3% (lowers Q3 dividend to $0.25 per share from $0.28 in prior quarter), IAG -3% (its partners in the Yatela Mine in Mali to suspend mining excavation activities), NOK -1.6% (still checking; co announced release of 2 new camera phones this morning).
Интересные новостные акции NYSEи NASDAQ:
HAL – лонг выше 50.50
SOHU – ниже 68.00 – шорт, выше 69.00 смотрим акцию в лонг.
Спайдер остается без изменений перед открытием торгов на NYSE.
Европейские индексы на отрицательной территории.
SPY (внутридневной график) боковое движение на премаркете. Сопротивление: 169.75 Поддержка: 168.75
Премаркет NYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: ULTA +14.3%, LFVN +5.9%, UNFI +4.2%, ALOG +3.2%, MBII +1.8%.
Other news: SGMO +4.6% (announced presentation of clinical data demonstrating functional control of viremia in HIV-infected subjects treated SB-728-T), SFNC +2.9% (to acquire Metropolitan National Bank), CTIC +2.8% (announces sales of Conv Pref Stock), LDK +2.6% (engages financial advisor for offshore debt obligations), SUNE +1.1% (public offering of 30 mln shares of common stock at a price of $7.25/share), EVTC +0.7% (prices 20 mln shares of common stock by affiliate of Apollo Global Mgmt and other selling shareholders at $22.50 per share ).
Analyst comments: OCLR +6.2% (upgraded to Buy from Neutral at B. Riley & Co), SWY +3.2% (upgraded to Outperform from Neutral at Credit Suisse), SFNC +2.9% (pgraded to Outperform from Mkt Perform at Raymond James, upgraded to Overweight from Equal-Weight at a boutique firm), WFT +2% (upgraded to Outperform from Neutral at Credit Suisse), INTC +1.9% (upgraded to Buy from Hold at Jefferies), LULU +1.4% (upgraded to Outperform from Neutral at Credit Suisse), AET +1.2% (pgraded to Buy from Neutral at BofA/Merrill), CMC +1.1% (upgraded to Neutral from Underperform at BofA/Merrill)
Gapping down:
In reaction to disappointing earnings/guidance: COV -2.3%.
Select metals/mining stocks trading lower: MT -1.6%, RIO -1.5%, AU -1.5%.
Select names showing early weakness following public offerings: GALE -10.1% (announced proposed public offering of common stock and warrants, size not disclosed), ARTX -8.3% (announces proposed public offering of common stock- size not disclosed), ARTX -8.3% (offering of ~3.43 mln shares of its common stock at a purchase price of $1.75/share), NSPH -5.5% (announced commencement of public offering of common stock, size not disclosed), PVR -4% (announces public offering of 5.5 mln common units), SSYS -3.7% (prices 4.5 mln shares of ordinary shares at $93.00 per share), MKTO -2.3% (prices 6 mln share of common stock follow-on offering at $35.50 per share), DRWI -2.2% (announces proposed public offering of common units), EMKR -1.9% (intends to offer 2.5 mln shares of common stock in public offering ), NXPI -1.6% (selling shareholders commence secondary offering of 25 mln shares of common stock), HAIN -1.4% (announced sale of 3,589,963 shares of common stock by selling stockholders), SN -1.4% prices 9.6 mln shares of the Company's common stock at a price of $23.00/share).
Other news: DCTH -5.4% (receives complete response letter from fda for Melbleztm kit new drug application), GFI -1.7% (S African miner unions have ended strike and have agreed to 12% pay hike, according to reports ), YHOO -1.1% (Alibaba.com IPO may delayed due to terms of Yahoo (YHOO) stake deal, according to reports), TSLA -0.9% (Elon Musk says it is 'not as crazy' in reference to shorting the stock at these levels in FBN interview; recall he made a similar statement about the co's stock valuation a few weeks ago).
Analyst comments: MPWR -2.9% (downgraded to Hold from Buy at Needham), UA -1.4% (downgraded to Neutral from Outperform at Credit Suisse ), AXLL -1.4% (downgraded to Neutral from Buy at BofA/Merrill), HMY -1.4% (downgraded to Sell from Neutral at Goldman), RIG -0.9% (downgraded to Mkt Perform from Outperform at Bernstein).
Интересные новостные акции NYSEи NASDAQ:
COV – шорт ниже 60.00, при закреплении выше – лонг.
ULTA – шорт ниже 112.00
LULU – шорт ниже 65.30, лонг при закреплении выше 60.00
Оставить комментарий
